The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Wnt/β-catenin-driven EMT regulation in human cancers
Open accessAbstract
Metastasis accounts for 90% of cancer-related deaths among the patients. The transformation of epithelial cells into mesenchymal cells with molecular alterations can occur during epithelial–mesenchymal transition (EMT). The EMT mechanism accelerates the cancer metastasis and drug resistance ability in human cancers. Among the different regulators of EMT, Wnt/β-catenin axis has been emerged as a versatile modulator. Wnt is in active form in physiological condition due to the function of GSK-3β that destructs β-catenin, while ligand–receptor interaction impairs GSK-3β function to increase β-catenin stability and promote its nuclear transfer. Regarding the oncogenic function of Wnt/β-catenin, its upregulation occurs in human cancers and it can accelerate EMT-mediated metastasis and drug resistance. The stimulation of Wnt by binding Wnt ligands into Frizzled receptors can enhance β-catenin accumulation in cytoplasm that stimulates EMT and related genes upon nuclear translocation. Wnt/β-catenin/EMT axis has been implicated in augmenting metastasis of both solid and hematological tumors. The Wnt/EMT-mediated cancer metastasis promotes the malignant behavior of tumor cells, causing therapy resistance. The Wnt/β-catenin/EMT axis can be modulated by upstream mediators in which non-coding RNAs are main regulators. Moreover, pharmacological intervention, mainly using phytochemicals, suppresses Wnt/EMT axis in metastasis suppression. Graphical abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inactivation of GSK3β disrupts the integrity and function of the destruction complex, thereby preventing β-catenin phosphorylation. As a result, unphosphorylated, stable β-catenin accumulates in the cytoplasm, translocates to the nucleus, and activates the transcription of its target genes, including c-Myc and Cyclin D1 [35, 46, 47, 52–55].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“EMT, a critical biological process by which tumor cells acquire motility and invasiveness, is a hallmark of metastasis and is frequently regulated by Wnt/β-catenin signaling [33–35].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [35]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, the activation of the Wnt/β-catenin/EMT axis accounts for the invasive characteristics we observed, linking this signaling cascade to ccRCC metastasis [34, 35].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Tyagi, A., Wu, S.-Y., Sharma, S., Wu, K., Zhao, D., Deshpande, R. P., Singh, R. N., Li, W., Topaloĝlu, Ü., Ruiz, J., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02322-w · Cited by 77
RetractedMa, B., Ma, J., Yang, Y., He, X., Pan, X.-M., Wang, Z., & Qian, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s238665 · Cited by 22
RetractedTu, H., Wang, W., Feng, Y., Zhang, L., Zhou, H., Cheng, C., Ji, L., Cai, Q., & Feng, Y. (2022) · Bioengineered · doi:10.1080/21655979.2022.2065945 · Cited by 10
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712 · cited 1×
“Ovarian cancer (OC) is another malignancy of gynecological tumors and the second leading cause of death [123].”
BackgroundOstrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Cited by
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Xue, C., Chu, Q., Shi, Q., Zeng, Y., Lu, J., & Li, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02142-w · Cited by 281
Ji, X., Yun, Y., Zhu, Z., Wu, T., Ruan, M., Fan, Y., & Zhang, Q. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04266-7
“As a result, unphosphorylated, stable β-catenin accumulates in the cytoplasm, translocates to the nucleus, and activates the transcription of its target genes, including c-Myc and Cyclin D1 [35, 46, 47, 52– 55].”
Metadata
- Authors
- Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R.
- Affiliations
- First Affiliated Hospital of Zhengzhou University (CN)
- Xian Yang Central Hospital (CN)
- Fudan University (CN)
- Benedictine University (US)
- Corresponding author
- Ashrafizadeh, Milad
- Tian, Yu
- Sun, Ranran
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2024-02-09
- Volume
- 81
- Issue
- 1
- Pages
- 79-79
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC10857981
- OpenAlex
- W4391691695
- Cited by
- 321
- References
- 239
- Citations by year
- 2026: 102 · 2025: 163 · 2024: 56
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2026-04-10)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cellular and Molecular Life Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Young and Middle-aged Health Science and Technology Innovation Talents in 2020 (YXKC2020055)
- Medical Science and Technology Project of Henan Province (SBGJ202002077)
- Natural Science Foundation of Henan Province of China (202300410460)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- Wnt/β-catenin signaling, epithelial-mesenchymal transition, metastasis, drug resistance, GSK3β, Frizzled receptors, β-catenin nuclear translocation, non-coding RNA, phytochemicals, hematologic cancer, solid tumors
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Cell Movement, Humans, Neoplasms, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, beta Catenin, Epithelial-Mesenchymal Transition, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Wnt/β-catenin-driven EMT regulation in human cancers. https://app.cochat.ai/papers/10.1007/s00018-023-05099-7
- The paper
- Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024). Wnt/β-catenin-driven EMT regulation in human cancers. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-023-05099-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.